| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
GeneDx Holdings Corp.
13D/A
WGS · 81663L200
|
17.9% |
5/22/2026
Event 5/20/2026
|
||||
| CMLS Holdings LLC | 1.8% | |||||
| C-LSH LLC | 1.8% | |||||
| M-LSH LLC | 1.8% | |||||
| Casdin Capital, LLC | 11.8% | |||||
| Casdin Partners Master Fund, L.P. | 11.8% | |||||
| Casdin Partners GP, LLC | 11.9% | |||||
| Eli Casdin | 13.7% | |||||
| Keith A. Meister | 17.9% | |||||
| Corvex Management LP | 16.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.